Eli Lilly Starts Human Study of Potential COVID-19 Antibody Test

Companies and research institutions around the world are racing to find a viable treatment for COVID-19, which has already caused ~370,000 deaths worldwide and continues to rise. Eli Lilly recently announced their progress, and are moving into the human study portion of their antibody treatment. They have developed this treatment from a blood sample that was taken from one of the first patients in the United States to have recovered from the lung illness caused by COVID-19.

Eli Lilly is anticipating results to their study by end of June. Read more about the treatment here.